You searched for "AMM"

1492 results found

Anatomical and functional outcomes following switching from aflibercept to ranibizumab in NARMD

This is a six-month, prospective, single-arm study in the UK and Germany. A total of 100 patients were enrolled (one in the primary failure group, 99 in the suboptimal treatment response group), treated three-monthly intravitreal ranibizumab injections (0.5mg), and then...

New team member for Topcon Surgical

Topcon Great Britain Medical has announced a new addition to the Topcon Surgical team.

A randomised, controlled trial of oral propranolol in infantile haemangioma

Since its use was first reported in the New England Journal in 2008, propranolol has become the preferred treatment for infantile haemangiomas. However, there is no consensus as to the optimum dose or duration of treatment and there is a...

Inhibiting high-risk corneal allografts

The cornea is an immune privileged site and as such corneal transplants are very successful. However, in situations where this privilege is lost the failure rises substantially. To combat rejection inhibition of the immune responses depends on steroids and other...

The Oxford Ophthalmological Congress CIO (the OOC): Invitation to Tender for Conference Organisation & Event Management Services

The Oxford Ophthalmological Congress CIO (the OOC)Charity no. 1181776Invitation to Tender for Conference Organisation & Event Management Services The Oxford Ophthalmological Congress is an historic meeting, in its 103rd year, and the second largest ophthalmological meeting held in the UK....

New essential guide for practice teams from Optometry Today

Optometry Today (OT) publishes new Practice Team Guide in partnership with Johnson & Johnson Vision.

Renewed momentum in ocular gene and cell therapy, broadening application to chronic disease

Gene and cell therapies offer the prospect of ground-breaking new avenues for the treatment of diseases, reflected in a renewed explosion of interest and investment in retinal gene therapy. Rod McNeil reports recent clinical trial readouts across a diverse range...

RNIB introduces ground-breaking framework for Low Vision care

The Royal National Institute of Blind People (RNIB) is launching the development of a landmark set of guidelines and framework to help low vision clinics provide best practice care, which it will unveil today at a launch event at its state-of-the-art Low Vision Centre in the charity’s headquarters in London.

Refractionist’s shoulder?

After hearing the letter-box, I walked to the front door and stooped down to collect my latest edition of Eye News. I winced. Still, at least it would give me something to pass the time on this, my first day...

Paediatric ptosis

Manoj Parulekar and colleagues provide a comprehensive overview of the diagnosis, assessment and management of childhood ptosis. Blepharoptosis (commonly referred to as ptosis – Greek, πτῶσις, ‘to fall’) is a condition where the upper eyelid is in an abnormally low...

Improved efficacy expected with second-generation microinvasive glaucoma surgery (MIGS) devices

Microinvasive surgical approaches to primary open-angle glaucoma (POAG) offer minimally traumatic options for effective intraocular pressure (IOP) reduction in appropriately selected glaucoma patients. Increases in laser trabeculoplasty rates and wider adoption of glaucoma drainage device filtration procedures, together with the...

An update on inherited retinal disorders (part 2): Approaches to therapy for IRDs

Part 1 of this topic can be found here There are currently no proven cures for inherited retinal disease (IRD). However, multiple avenues of research are being investigated to better understand disease mechanisms and trial potential therapies that may slow...